Should Biogen Buy Alkermes? Post author:Sam Post published:February 27, 2018 Post category:BioPharma After a huge dry spell in M&A, 2018 is shaping up to be a great year for deal making. Source: BioSpace You Might Also Like Boy Wonder Roivant Bets $116 Million on Arbutus October 1, 2017 Biocept, Inc. Release: Company Awarded Patent In Australia For The Use Of Antibodies In Microchannels To Capture Circulating Tumor Cells And Other Rare Cells January 18, 2017 Adocia Announces First Quarter 2017 Financial Results April 17, 2017
Biocept, Inc. Release: Company Awarded Patent In Australia For The Use Of Antibodies In Microchannels To Capture Circulating Tumor Cells And Other Rare Cells January 18, 2017
